PL438097A1 - Sposób otrzymywania doustnego filmu zawierającego kannabidiol - Google Patents

Sposób otrzymywania doustnego filmu zawierającego kannabidiol

Info

Publication number
PL438097A1
PL438097A1 PL438097A PL43809721A PL438097A1 PL 438097 A1 PL438097 A1 PL 438097A1 PL 438097 A PL438097 A PL 438097A PL 43809721 A PL43809721 A PL 43809721A PL 438097 A1 PL438097 A1 PL 438097A1
Authority
PL
Poland
Prior art keywords
cannabidiol
solution
preparing
film containing
oral film
Prior art date
Application number
PL438097A
Other languages
English (en)
Other versions
PL245075B1 (pl
Inventor
Marcin BANACH
Olga DŁUGOSZ
Original Assignee
Dukebox Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dukebox Spółka Z Ograniczoną Odpowiedzialnością filed Critical Dukebox Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL438097A priority Critical patent/PL245075B1/pl
Publication of PL438097A1 publication Critical patent/PL438097A1/pl
Publication of PL245075B1 publication Critical patent/PL245075B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób otrzymywania doustnego filmu zawierającego kannabidiol o nanometrycznym rozmiarze cząstki, charakteryzujący się tym, że przygotowuje się roztwór wodny żelatyny albo gumy guar o stężeniu od 10 do 15% oraz roztwór izolatu kannabidiolu w propanodiolu albo w glikolu polietylenowym w stosunku masowym izolatu kannabidiolu do propanodiolu albo glikolu polietylenowego 1:1, po czym do roztworu żelatyny albo gumy guar dodaje się roztwór izolatu kannabidiolu przy stosunku masowym od 1:1 do 1,5:1, a następnie całość poddaje się działaniu ultradźwięków przez 5 do 15 min celem zdyspergowania, po czym gotową mieszaninę przenosi się do formy i pozostawia do zestalenia w temperaturze niższej albo równej 5°C.
PL438097A 2021-06-08 2021-06-08 Sposób otrzymywania doustnego filmu zawierającego kannabidiol PL245075B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL438097A PL245075B1 (pl) 2021-06-08 2021-06-08 Sposób otrzymywania doustnego filmu zawierającego kannabidiol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438097A PL245075B1 (pl) 2021-06-08 2021-06-08 Sposób otrzymywania doustnego filmu zawierającego kannabidiol

Publications (2)

Publication Number Publication Date
PL438097A1 true PL438097A1 (pl) 2022-12-12
PL245075B1 PL245075B1 (pl) 2024-05-06

Family

ID=84441524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438097A PL245075B1 (pl) 2021-06-08 2021-06-08 Sposób otrzymywania doustnego filmu zawierającego kannabidiol

Country Status (1)

Country Link
PL (1) PL245075B1 (pl)

Also Published As

Publication number Publication date
PL245075B1 (pl) 2024-05-06

Similar Documents

Publication Publication Date Title
BRPI0409357A (pt) pelìcula de gel termorreversìvel homogênea, processo para fabricar as pelìculas de gel, cápsulas moles, processo para fabricar as cápsulas moles, e, forma sólida
CL2019001447A1 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos.
AR042340A1 (es) Liberacion controlada de una sustancia activa a un entorno rico en grasa
BR112012025406B1 (pt) Método de preparação de uma cápsula dura de uso entérico
JP3672008B2 (ja) 硬質カプセル及びその製造方法
DE60319375D1 (de) Zweifach Coating-beschichteten Milchsäurenbakterienpulver mit Protein und Polysaccharid und das Verfahren zur deren Herstellung sowie deren Dosisform
NZ768717A (en) Sustained-release anesthetic compositions and methods of preparation thereof
PL438097A1 (pl) Sposób otrzymywania doustnego filmu zawierającego kannabidiol
DE60336602D1 (de) Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
CN101816622A (zh) 一种泡泡剂型染发剂及其制备方法
RU2009128065A (ru) Тонкий презерватив
CN113018275B (zh) 一种聚维酮空心胶囊及其生产工艺
JP2005137935A (ja) 硬質カプセル及びその製造方法
CN106732215A (zh) 一种用于香烟润香珠的增强溶胶及其制备方法
CN119587466A (zh) 盐酸阿莫罗芬搽剂及生产工艺
CH621259A5 (pl)
CN108697605B (zh) 感光染发剂
CN106491538B (zh) 卡巴匹林钙可溶性粉及其制备方法
IN2013CH05761A (pl)
JP5859696B1 (ja) ゲル状の組成物
HRP20250187T1 (hr) Pripravak i postupci za povećanje unosa željeza u sisavaca
CN106038323A (zh) 纳米精细型藻酸盐印模材料
CN101003663A (zh) 无溶剂型环氧树脂血管铸型剂
CN103110629B (zh) 复方酚麻美敏滴丸及其制备方法
DE904105C (de) Verfahren zum Vulkanisieren von Kautschukgegenstaenden